EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Sodium Zirconium Cyclosilicate on Volume Status in Maintenance Hemodialysis

Steven Fishbane iD, Laura M Dember iD, Michel Jadoul iD, Csaba P Kovesdy, Mahendra K Bijarnia, Priya Sekar, Charles A Herzog

Kidney360 · 06.08.2026

DOI: 10.34067/kid.0000001330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 06.08.2026. Verfasst von Steven Fishbane und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Effect of Sodium Zirconium Cyclosilicate on Arrythmia-Related Cardiovascular Outcomes in Participants on Chronic Hemodialysis with Recurrent Hyperkalemia (DIALIZE-Outcomes) trial evaluated the effect of sodium zirconium cyclosilicate (SZC) on arrhythmia-related cardiovascular outcomes among patients receiving maintenance hemodialysis. The study was terminated early because of a low event rate and high treatment discontinuation. As SZC exchanges sodium for potassium, volume expansion from increased sodium absorption is a potential adverse effect. This post hoc analysis evaluated the effects of SZC versus placebo on volume status.

Methods

Adults receiving maintenance hemodialysis with predialysis hyperkalemia (serum potassium ≥5.5 mmol/L) were randomized 1:1 to SZC (starting dose 5 g once daily on non-dialysis days, titrated as needed; N =1349) or placebo ( N =1341). Indicators of volume status included: adverse events (AEs) related to volume status, antihypertensive medication use, change in predialysis blood pressure, and change in interdialytic weight gain (IDWG).

Results

For the 2690 randomized participants, 62% were male, mean (SD) age was 56.1 (13.4) years, predialysis weight was 75.3 (19.8) kg, and dialysis vintage was 5.9 (5.3) years. In the SZC and placebo groups, there were similar proportions of participants with AEs of edema (5% versus 5%), heart failure (5% versus 5%), and hypertension (9% versus 8%). Mean (SD) changes from baseline to end of follow-up were similar between SZC and placebo for predialysis systolic (-2.1 [24.3] versus -2.2 [22.2] mm Hg) and diastolic (-0.9 [15.0] versus -0.8 [14.2] mm Hg) blood pressure, and IDWG (+0.2 [2.6] versus +0.1 [2.4] kg). The number of antihypertensive medications used was similar between SZC and placebo at baseline (85% versus 83%) and during follow-up (88% versus 86%).

Conclusions

In this post hoc analysis of a large trial of patients with hyperkalemia receiving hemodialysis, there was no clinical evidence of volume changes with SZC. This supports the use of SZC as hyperkalemia treatment among patients receiving hemodialysis—a population at high risk for hypervolemia.

Autor:innen und Institutionen

  • Division of Nephrology, Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.
  • Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Nephrology, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee.
  • Cardiovascular, Renal, and Metabolism - Biometrics, AstraZeneca India Pvt Ltd, Bangalore, India.
  • BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.

ORCID-Profile: Steven Fishbane, Laura M Dember, Michel Jadoul

Zitieren

APA

Fishbane, S., Dember, L. M., Jadoul, M., Kovesdy, C. P., Bijarnia, M. K., Sekar, P., & Herzog, C. A. (2026). Effects of Sodium Zirconium Cyclosilicate on Volume Status in Maintenance Hemodialysis. Kidney360. https://doi.org/10.34067/kid.0000001330

Vancouver

Fishbane S, Dember LM, Jadoul M, Kovesdy CP, Bijarnia MK, Sekar P, et al. Effects of Sodium Zirconium Cyclosilicate on Volume Status in Maintenance Hemodialysis. Kidney360. 2026. doi:10.34067/kid.0000001330

BibTeX
@article{Fishbane2026,
  author = {Fishbane, Steven and Dember, Laura M and Jadoul, Michel and Kovesdy, Csaba P and Bijarnia, Mahendra K and Sekar, Priya and Herzog, Charles A},
  title = {Effects of Sodium Zirconium Cyclosilicate on Volume Status in Maintenance Hemodialysis},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001330}
}
Kostenlos starten →